External Advisory Board
The EAB consists of a group of outstanding scientists with extensive leadership experience and sustained records of research productivity and program development. The EAB meets once per year to review the Investigators, the core facilities and the administration of the program. The EAB advises the Program Director with respect to the research projects of the junior investigators and the mentoring efforts. The EAB additionally provides areas of expertise for the junior faculty in areas of Cancer Genetics and Gene Expression.
Dr. Friedmann holds the Muriel Jeannette Whitehill Chair in Biomedical Ethics and serves as the Director of the Program in Gene Therapy at UCSD. He also served as Co-leader of the UCSD Cancer Genetics Program for five years. He has a broad background in human genetics, as well as technical molecular biology. Dr. Friedmann has a 30-year history of NIH funding and currently is supported by two NIH R01 grants. He has served on HIH study section and participates in a number of advisory committees. His outstanding tradition of mentoring and faculty development makes Dr. Friedmann an ideal member of the Advisory Board.
Dr. Glover is a Professor of Human Genetics at the University of Michigan. He has a long track record in the field of genetic instability and has several NIH grants as well as private foundation support. Dr. Glover has served on NIH study section as well as the board of the March of Dimes. He is committed to fostering the careers of young scientists and is a valuable asset to the project.
Dr. Stiles has a long history of work on the cell cycle and the molecular basis of tumorigenesis. He is a professor of Microbiology and Molecular Genetics at Harvard Medical School and Deputy Director of the DFCI Mahoney Center for Neuro Oncology. He has served as a consultant to a number of agencies in cancer research. Dr. Stiles also has an extensive history of NIH funding. His strong record of mentoring young faculty, both from his laboratory and those entering the DFCI, is a perfect fit for the EAB.
Dr. Wang is an extremely successful scientist in the field of signaling associated with genetic instability. He has an outstanding record of peer reviewed funding and currently has multiple NIH grants. He has a prolific record of postdoctoral training and has served on several different study sections and editorial boards. Dr. Wang’s expertise is invaluable to the junior investigators.